Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and the Risk of Cirrhosis in Patients with Chronic Hepatitis B—A Retrospective Cohort Study-Reference-Cited by-同舟云学术

Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and the Risk of Cirrhosis in Patients with Chronic Hepatitis B—A Retrospective Cohort Study

Published:2022-08 Issue: Volume:Volume 15 Page:2311-2322
ISSN:1178-7007
Container-title:Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
language:en
Short-container-title:DMSO

Author:

Wang Qing-Xia,Xue Jiao^ORCID,Shi Mei-Jie,Xie Yu-Bao,Xiao Huan-Ming,Li Sheng,Lin Ming,Chi Xiao-Ling

Publisher

Informa UK Limited

Subject

Pharmacology,Internal Medicine

Reference35 articles.

1. Hepatitis B Virus Epidemiology

2. Epidemiology and Management of Hepatocellular Carcinoma

3. Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis

4. Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission

5. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interferon-α could induce liver steatosis to promote HBsAg loss by increasing triglyceride level;Heliyon;2024-06

2. Prevalence of metabolic syndrome among patients with hepatocellular carcinoma of different etiologies: a retrospective study;Infectious Agents and Cancer;2024-05-01

3. Influence of metabolic dysfunction-associated fatty liver disease on the prognosis of patients with HBV-related acute-on-chronic liver failure;Expert Review of Gastroenterology & Hepatology;2024-01-08

4. Proportion of metabolic syndrome in hepatocellular carcinoma patients with different etiologies: a retrospective study;2023-11-09

5. ACLY as a modulator of liver cell functions and its role in Metabolic Dysfunction-Associated Steatohepatitis;Journal of Translational Medicine;2023-08-24